Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

AstraZenecas Imfinzi Combo Shows Strong Survival Benefit in Liver Cancer Trial

AstraZeneca Koselugo recommended for approval in EU for plexiform neurofibromas in adults with neurofibromatosis type 1

Written By Ruchika Sharma28 Sept 2025 4:45 PM IST

AstraZeneca has announced that Koselugo (selumetinib), an oral, selective MEK inhibitor, has been recommended for approval in the European...

Abbvie gets USFDA approval for updated indication statement for Rinvoq for Inflammatory Bowel Disease

AbbVie submits new drug application to USFDA for Tavapadon for Parkinsons disease

Written By Ruchika Sharma28 Sept 2025 4:45 PM IST

North Chicago: AbbVie has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for...

Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boom

Eli Lilly Kisunla gets marketing authorization from European Commission for early symptomatic Alzheimer's disease

Written By Ruchika Sharma28 Sept 2025 11:21 AM IST

Indianapolis: Eli Lilly and Company has announced that the European Commission (EC) has granted marketing authorization for Kisunla...

Patent infringement: Factor Bioscience sues AstraZeneca, Cellectis over gene-editing technology

Written By Ruchika Sharma27 Sept 2025 5:30 PM IST

Biotech firm Factor Bioscience has filed a lawsuit against Cellectis and AstraZeneca, accusing the companies of allegedly infringing three patents...

Eli Lilly to Acquire Ajax Therapeutics in USD 2.3 Billion Cancer Drug Push

Eli Lilly Inluriyo gets USFDA nod for adults with advanced breast cancer

Written By Ruchika Sharma26 Sept 2025 12:00 PM IST

Indianapolis: Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved Inluriyo (imlunestrant,...

Lupin Receives USFDA EIR with VAI Status for Goa Manufacturing Plant

Lupin gets tentative USFDA nod for HIV drug

Written By Ruchika Sharma24 Sept 2025 5:16 PM IST

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug...

Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 crore

Pfizer to buy obesity drug maker Metsera

Written By Ruchika Sharma24 Sept 2025 2:47 PM IST

New York: Pfizer Inc. and Metsera, Inc. have announced that the companies have entered into a definitive agreement under which Pfizer will...

Sanofi India appoints Haresh Vala as Company Secretary, Compliance Officer

Sanofi SAR446268 wins USFDA fast track designation for non-congenital myotonic dystrophy type 1

Written By Ruchika Sharma24 Sept 2025 1:45 PM IST

Paris: Sanofi has announced that the US Food and Drug Administration (FDA) has granted fast track designation to SAR446268, Sanofi's one-time AAV...

AstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia Treatment

AstraZeneca-Daiichi Sankyo get USFDA grants priority review for Enhertu combo for 1st line HER2+ Breast cancer treatment

Written By Ruchika Sharma24 Sept 2025 12:46 PM IST

Cambridge: AstraZeneca and Daiichi Sankyo's supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) in combination...

Serum Institute, Vidal Health Partner for Digital Cashless HPV Vaccination Programme

SII, Vidal Health join hands on HPV vaccine access

Written By Ruchika Sharma24 Sept 2025 10:55 AM IST

Mumbai: Serum Institute of India Pvt. Ltd., part of Cyrus Poonawalla Group, and Vidal Health, a 100 percent subsidiary of Bajaj...

Marksans Pharma UK arm Relonchem gets marketing nod for high BP drug

Written By Ruchika Sharma23 Sept 2025 2:30 PM IST

Mumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary in UK, Relonchem Limited, has received marketing...

Shilpa Medicare bags initial authorization for Rotigotine Transdermal Patch from Europe

Shilpa Medicare gets initial authorization from EMA for Rivaroxaban Orodispersible Films

Written By Ruchika Sharma23 Sept 2025 12:30 PM IST

Bengaluru: Shilpa Medicare Limited, headquartered at Raichur, Karnataka, India, has received the initial authorization from European...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok